More News

21 Sep 2017 Spark Therapeutics Enters into Licensing Agreement with Genethon
21 Sep 2017 Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd.
21 Sep 2017 Glythera and IONTAS Enter into License Agreement for the Development of Multiple Antibodies for Next-Generation Antibody Drug Conjugates
20 Sep 2017 Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences
19 Sep 2017 Ultragenyx Proposes to Acquire Dimension Therapeutics for $5.50 Per Share in Cash
18 Sep 2017 Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases
14 Sep 2017 MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid Leukemia Therapies
14 Sep 2017 Ablexis Announces Licensing of the AlivaMab Mouse to Five Prime Therapeutics
14 Sep 2017 Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties
14 Sep 2017 Bristol-Myers Squibb and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology
13 Sep 2017 Geom Therapeutics Announces Agreement with National Institute of Allergy and Infectious Diseases (NIAID) for Clinical Advancement of GT-1
12 Sep 2017 AbCellera Launches Antibody Discovery Collaboration with GSK
09 Sep 2017 Phosplatin Therapeutics Announces Collaboration with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate Combination of PT-112 and Avelumab in Phase I / II Studies
07 Sep 2017 Gritstone Oncology Secures $92.7 Million in Series B Financing
07 Sep 2017 Boehringer Ingelheim and Gubra collaborate to develop next generation obesity treatments
07 Sep 2017 Iovance Biotherapeutics Enters into a Research Collaboration Focused on Hematologic Malignancies with The Ohio State University Comprehensive Cancer Center
07 Sep 2017 Zealand and Orbit Discovery enter into research collaboration
07 Sep 2017 Evotec and ABIVAX Enter into Strategic Collaboration to Develop Novel Antiviral Agents
06 Sep 2017 Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
06 Sep 2017 Morphotek Announces Collaboration Agreement With The Johns Hopkins University To Research And Develop Novel Monoclonal Antibody-Based Therapies Targeting Missplicing-Associated Surface Antigens
06 Sep 2017 Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology
06 Sep 2017 MEI Pharma Announces Exclusive License Agreement with Presage Biosciences for Voruciclib, An Oral, Selective CDK Inhibitor
06 Sep 2017 BioNTech AG Enters into Licensing Agreement with CELLSCRIPT, LLC as it Advances Development of Messenger RNA Encoding Bispecific Antibodies and other Therapeutic Proteins
06 Sep 2017 Bioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration to Develop Therapies for Haemophilia and Sickle Cell Disease
05 Sep 2017 Retrophin Announces Cooperative Research and Development Agreement with NCATS and NGLY1.org to Identify Potential Small Molecule Therapeutics for NGLY1 Deficiency

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top